By Jeff Montgomery ( January 25, 2017, 9:04 PM EST) -- Shareholder attempts to rescue a challenge to the $13.1 billion Salix Pharmaceuticals Inc. merger with Valeant Pharmaceuticals International Inc. in 2015 hit turbulence in Delaware's Supreme Court on Wednesday, with the court inquiring more than once: "Is there anything else?"...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.